Patent details
EP2496249 Title: GLP-1 RECEPTOR AGONIST FOR USE IN TREATING OBSTRUCTIVE SLEEP APNEA
Basic Information
- Publication number:
- EP2496249
- PCT Application Number:
- PCT/US/2010/054553
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP108289323
- PCT Publication Number:
- WO/2011/056713
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- GLP-1 RECEPTOR AGONIST FOR USE IN TREATING OBSTRUCTIVE SLEEP APNEA
- French Title of Invention:
- AGONISTE DU RÉCEPTEUR DU GLP-1 POUR L'UTILISATION DANS LE TRAITEMENT DE L'APNÉE OBSTRUCTIVE DU SOMMEIL
- German Title of Invention:
- GLP-1-REZEPTOR-AGONISTEN ZUR VERWENDUNG IN DER BEHANDLUNG VON OBSTRUKTIVER SCHLAFAPNOE
- SPC Number:
Dates
- Filing date:
- 28/10/2010
- Grant date:
- 09/03/2016
- EP Publication Date:
- 09/03/2016
- PCT Publication Date:
- 12/05/2011
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 12/09/2012
- EP B1 Publication Date:
- 09/03/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 28/10/2016
- Expiration date:
- 28/10/2030
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 28/10/2010
- Name:
- Amylin Pharmaceuticals LLC
- Address:
- 1800 Concord Pike, Wilmington, DE 19850, United States (US)
- Name:
- Eli Lilly and Company
- Address:
- Lilly Corporate Center, Indianapolis, IN 46285, United States (US)
Inventor
- Name:
- VAN CAUTER Eve
- Address:
- United States (US)
Priority
- Priority Number:
- 257603 P
- Priority Date:
- 03/11/2009
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 38/26;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|